VWF and platelet-type von Willebrand disease: In addition, these results highlighted LSECs (the physiological source of factor VIII and von Willebrand factor) as an alternative and more physiologically relevant target than hepatocytes for hemophilia A57 or von Willebrand disease gene therapy58,59.